High officials in Pfizer evaluate their strategies to improve the protection of patents Pfizer worldwide. The outcome of the Uruguay Round of the GATT negotiations is uncertain, it is not clear whether the agreement is acceptable intellectual property protection will appear. The case describes how Pfizer helped turn the intellectual property as a lawyer with respect to international trade worldwide concern due to the close cooperation with the U.S. government, the leadership in the formation of the tripartite coalition of American, Japanese and European industry and to mobilize Pfizer organization. Shows how far the company can go to protect their intellectual property in the world, where the concept of intellectual property is not recognized or accepted. Can also be used to discuss the effectiveness and legitimacy of the strategy of the company Pfizer, conflicts between industrialized countries and developing countries, the prospects for international trade and national sovereignty, and the question of appropriate standards for the protection of intellectual property. "Hide
by Lynn Sharp Paine, Michael A. Santoro Source: Harvard Business School 27 pages. Publication Date: February 13, 1992. Prod. #: 392073-PDF-ENG
Related Case Solutions & Analyses:
Hewlett-Packard: Singapore (A)
Athens Glass Works
ZipDial: Reaching The Next 3 Billion Consumers
Google Inc. in 2014 (Abridged)
H-Soft (B-2): Vikram Sharma
Search Costs and Market Efficiency in Emerging Economies
Vodafone in Japan (B)
Business Design: Becoming a Bilateral Thinker
How to Find Answers Within Your Company
Mobil in Aceh, Indonesia (A)
